Anti-TB substance BTZ-043 passes Clinical Trial Phase Ia milestone

News Releases

Find the latest News in

Home / News Releases

Anti-TB substance BTZ-043 passes Clinical Trial Phase Ia milestone

Wednesday 17th July 2019

By HAPILA GmbH Learn More >

PHOENIX group focuses on growth and digitalisation

Friday 12th July 2019

By PHOENIX group Learn More >

New Bonfiglioli Engineering HQ opens for business

New Bonfiglioli Engineering HQ opens for business

Tuesday 2nd July 2019

By Bonfiglioli Engineering… Learn More >

SIRION highlights France as leading force in gene and cell therapy

Friday 28th June 2019

By SIRION Biotech… Learn More >

Leading pharma magazine focuses on Zenatek ZTS real-time tracking

Leading pharma magazine focuses on Zenatek ZTS real-time tracking

Friday 28th June 2019

By ZENATEK S.a.r.l Learn More >

Progress-PME celebrates 20th Anniversary

Progress-PME celebrates 20th Anniversary

Thursday 27th June 2019

By Progress Project… Learn More >

NIAID allergy institute chooses SIRION LentiBOOST™ technology to strengthen SCID-X1 immunodeficiency study

Tuesday 25th June 2019

By SIRION Biotech… Learn More >

Phage Consultants returning to BIO World Congress 2019 in Iowa

Phage Consultants returning to BIO World Congress 2019 in Iowa

Monday 24th June 2019

By Phage Consultants Learn More >

Skyepharma extends complex project capabilities with ERP implementation

Monday 24th June 2019

By Skyepharma Production… Learn More >

TAmiRNA brings miRNA tools for children’s bone diseases to ICCBH Salzburg

Tuesday 18th June 2019

By TAmiRNA GmbH Learn More >

Progress-PME highlights CMC expertise at HollandBIO 2019

Progress-PME highlights CMC expertise at HollandBIO 2019

Friday 14th June 2019

By Progress Project… Learn More >

Particle Analytical showing advanced CRO and CDMO capabilities at BOS Basel

Thursday 13th June 2019

By Particle Analytical… Learn More >